IL141446A0 - Benzazine derivatives as phosphodiesterase 4 inhibitors - Google Patents

Benzazine derivatives as phosphodiesterase 4 inhibitors

Info

Publication number
IL141446A0
IL141446A0 IL14144699A IL14144699A IL141446A0 IL 141446 A0 IL141446 A0 IL 141446A0 IL 14144699 A IL14144699 A IL 14144699A IL 14144699 A IL14144699 A IL 14144699A IL 141446 A0 IL141446 A0 IL 141446A0
Authority
IL
Israel
Prior art keywords
phosphodiesterase
inhibitors
benzazine derivatives
benzazine
derivatives
Prior art date
Application number
IL14144699A
Other languages
English (en)
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of IL141446A0 publication Critical patent/IL141446A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14144699A 1998-10-15 1999-10-01 Benzazine derivatives as phosphodiesterase 4 inhibitors IL141446A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002216A IT1302677B1 (it) 1998-10-15 1998-10-15 Derivati benzazinici inibitori della fosfodiesterasi 4
PCT/EP1999/007302 WO2000021947A1 (fr) 1998-10-15 1999-10-01 Derives de benzazine utilises comme inhibiteurs de phosphodiesterase 4

Publications (1)

Publication Number Publication Date
IL141446A0 true IL141446A0 (en) 2002-03-10

Family

ID=11380876

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14144699A IL141446A0 (en) 1998-10-15 1999-10-01 Benzazine derivatives as phosphodiesterase 4 inhibitors

Country Status (8)

Country Link
US (1) US6358973B1 (fr)
EP (1) EP1121353A1 (fr)
JP (1) JP2002527430A (fr)
AU (1) AU769338B2 (fr)
CA (1) CA2344694A1 (fr)
IL (1) IL141446A0 (fr)
IT (1) IT1302677B1 (fr)
WO (1) WO2000021947A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1816527A (zh) 2003-06-06 2006-08-09 菲布罗根有限公司 含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途
CN101374815B (zh) * 2006-01-27 2013-07-17 菲布罗根有限公司 使低氧诱导因子(hif)稳定的氰基异喹啉化合物
BRPI0710527B8 (pt) * 2006-04-04 2021-05-25 Fibrogen Inc compostos de pirrolo- e tiazolo-piridina e composição farmacêutica que os compreende
WO2008026704A1 (fr) * 2006-08-31 2008-03-06 Kyowa Hakko Kogyo Co., Ltd. Dérivé d'isoquinoline
TW200902025A (en) * 2007-04-11 2009-01-16 Alcon Res Ltd Use of an inhibitor of TNF α plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
JP5649584B2 (ja) 2008-11-14 2015-01-07 フィブロジェン インコーポレイテッド Hifヒドロキシラーゼ阻害剤としてのチオクロメン誘導体
MX2012003693A (es) * 2009-10-01 2012-04-19 Alcon Res Ltd Composiciones de olopatadine y usos de las mismas.
AU2013229922B2 (en) 2012-03-09 2017-09-28 Fibrogen, Inc. 4 -hydroxy- isoquinoline compounds as HIF hydroxylase inhibitors
US8883823B2 (en) 2012-07-16 2014-11-11 Fibrogen, Inc. Crystalline forms of a prolyl hydroxylase inhibitor
LT2872488T (lt) 2012-07-16 2018-10-25 Fibrogen, Inc. Kristalinės prolilhidroksilazės inhibitoriaus formos
US9340511B2 (en) 2012-07-16 2016-05-17 Fibrogen, Inc. Process for making isoquinoline compounds
RU2666144C2 (ru) 2013-01-24 2018-09-06 Фиброген, Инк. Кристаллические формы { [1-циано-5-(4-хлорофенокси)-4-гидроксиизохинолин-3-карбонил]-амино} -уксусной кислоты
CN108929228A (zh) * 2018-07-09 2018-12-04 上海华堇生物技术有限责任公司 一种3-甲氧基-β-硝基苯乙烯的新制备方法
CN113423435A (zh) 2018-12-28 2021-09-21 雷杰纳荣制药公司 使用花生四烯酸15-脂氧合酶(alox15)抑制剂治疗呼吸系统病症

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1199768A (en) * 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
WO1988007041A1 (fr) * 1987-03-12 1988-09-22 Huhtamäki Oy Derives d'isoquinoline, fabrication et utilisation
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
US5455252A (en) * 1993-03-31 1995-10-03 Syntex (U.S.A.) Inc. Optionally substituted 6,8-quinolines
JP3276762B2 (ja) * 1993-12-28 2002-04-22 日本臓器製薬株式会社 イソキノリン誘導体を含有する医薬組成物
HU219864B (hu) * 1994-08-09 2001-08-28 Eisai Co., Ltd. cGMP-PDE inhibitor kondenzált piridazinszármazékok és alkalmazásuk
EP0841929B1 (fr) * 1995-08-02 2003-05-07 Darwin Discovery Limited Quinolones et leur utilisation therapeutique
AU706110B2 (en) * 1996-04-13 1999-06-10 Astrazeneca Ab Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
ID19155A (id) * 1996-12-13 1998-06-18 Tanabe Seiyaku Co Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
IT1296985B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4

Also Published As

Publication number Publication date
EP1121353A1 (fr) 2001-08-08
AU769338B2 (en) 2004-01-22
IT1302677B1 (it) 2000-09-29
JP2002527430A (ja) 2002-08-27
ITMI982216A1 (it) 2000-04-15
US6358973B1 (en) 2002-03-19
ITMI982216A0 (it) 1998-10-15
WO2000021947A1 (fr) 2000-04-20
CA2344694A1 (fr) 2000-04-20
AU6332299A (en) 2000-05-01

Similar Documents

Publication Publication Date Title
IL141445A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
HUP0103349A3 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
GB2346877B (en) 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
HUP0001848A3 (en) 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
PL346155A1 (en) 1h-imidazopyridine derivatives
IL127260A0 (en) Hydroxy-phosphinyl derivatives useful as naaladase inhibitors
PL345540A1 (en) Thiobenzimidazole derivatives
SG71898A1 (en) Benzosulfone derivatives
HK1041407B (zh) 作為環氧酶-2抑制劑的二芳基苯並吡喃衍生物
GB9809664D0 (en) a-Ketoamide derivatives
HK1039124B (zh) 二氮雜萘衍生物磷酸二酯酶4抑制劑
AU2274299A (en) Benzazine derivatives phosphodiesterase 4 inhibitors
IL141446A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
EG23802A (en) 2-Phenylpyran-4-one derivatives
AU4501199A (en) 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
GB9827729D0 (en) Thieno-indole derivatives
EP1061912A4 (fr) Derives de phenanthrofuran
IL139276A0 (en) Cyclohexenondioxthio chromanoyl derivatives
HK1042478A1 (zh) 2-氧代-2h-喹啉衍生物
SI1109560T1 (en) Compounds useful as aicarft inhibitors
GB9812410D0 (en) Heterocyclic derivatives
GB9809351D0 (en) Heterocyclic derivatives
GB9827817D0 (en) Type 11 Dehydroquinase inhibitors
GB9816279D0 (en) Arylthiazolidinedione derivatives
SI1051395T1 (sl) N-hidroksiformamidni derivati